标题
Immune modulatory effects of statins
作者
关键词
-
出版物
IMMUNOLOGY
Volume 154, Issue 1, Pages 69-75
出版商
Wiley
发表日期
2018-02-02
DOI
10.1111/imm.12902
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Metabolic Induction of Trained Immunity through the Mevalonate Pathway
- (2018) Siroon Bekkering et al. CELL
- Combination therapy of lovastatin and AMP-activated protein kinase activator improves mitochondrial and peroxisomal functions and clinical disease in experimental autoimmune encephalomyelitis model
- (2018) Inderjit Singh et al. IMMUNOLOGY
- Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial
- (2017) Dennis Chan et al. LANCET NEUROLOGY
- MicroRNA-146a reduces MHC-II expression via targeting JAK/STAT signaling in dendritic cells after stem cell transplantation
- (2017) N Stickel et al. LEUKEMIA
- Simvastatin ameliorates graft-vs-host disease by regulating angiopoietin-1 and angiopoietin-2 in a murine model
- (2017) Peng Zheng et al. LEUKEMIA RESEARCH
- Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy
- (2017) Robert Zeiser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets
- (2017) Robert Zeiser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Statin impact on disease activity and C-reactive protein concentrations in systemic lupus erythematosus patients: A systematic review and meta-analysis of controlled trials
- (2016) Amirhossein Sahebkar et al. AUTOIMMUNITY REVIEWS
- Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT)
- (2016) Yvonne A. Efebera et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Cardiovascular Outcomes Associated with Lowering Low-density Lipoprotein Cholesterol in Rheumatoid Arthritis and Matched Nonrheumatoid Arthritis
- (2016) J. An et al. JOURNAL OF RHEUMATOLOGY
- Statin Treatment in Multiple Sclerosis: A Systematic Review and Meta-Analysis
- (2015) Gorm Pihl-Jensen et al. CNS DRUGS
- Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
- (2015) R Zeiser et al. LEUKEMIA
- Lovastatin blocks Kv1.3 channel in human T cells: a new mechanism to explain its immunomodulatory properties
- (2015) Ning Zhao et al. Scientific Reports
- Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration
- (2015) Daniel May de Oliveira et al. INFLAMMOPHARMACOLOGY
- Simvastatin Inhibits IL-17 Secretion by Targeting Multiple IL-17-Regulatory Cytokines and by Inhibiting the Expression of IL-17 Transcription Factor RORC in CD4+ Lymphocytes
- (2014) X. Zhang et al. JOURNAL OF IMMUNOLOGY
- Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity
- (2014) Martin S Weber et al. Journal of Neuroinflammation
- Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised study*
- (2013) Iain B McInnes et al. ANNALS OF THE RHEUMATIC DISEASES
- Inflammatory neovascularization during graft-versus-host disease is regulated by v integrin and miR-100
- (2013) F. Leonhardt et al. BLOOD
- Sibling Donor and Recipient Immune Modulation With Atorvastatin for the Prophylaxis of Acute Graft-Versus-Host Disease
- (2013) Mehdi Hamadani et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells
- (2012) A.-K. Hechinger et al. HAEMATOLOGICA
- Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr−/−mice
- (2011) Sander I van Leuven et al. ANNALS OF THE RHEUMATIC DISEASES
- Statin therapy in lupus-mediated atherogenesis: two birds with one stone?
- (2010) S. I. van Leuven et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of Recipient Statin Treatment on Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation
- (2010) Marcello Rotta et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis
- (2010) Jennifer MP Woo et al. ARTHRITIS RESEARCH & THERAPY
- Blocking LFA-1 Activation with Lovastatin Prevents Graft-versus-Host Disease in Mouse Bone Marrow Transplantation
- (2009) Yang Wang et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Donor statin treatment protects against severe acute graft-versus-host disease after related allogeneic hematopoietic cell transplantation
- (2009) M. Rotta et al. BLOOD
- Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes
- (2009) F. Montecucco et al. RHEUMATOLOGY
- Failure of oral atorvastatin to modulate a murine model of systemic lupus erythematosus
- (2008) Kareem L. Graham et al. ARTHRITIS AND RHEUMATISM
- Statins inhibit human APC function: implications for the treatment of GVHD
- (2008) A. Shimabukuro-Vornhagen et al. BLOOD
- The impact of HMG-CoA reductase inhibition on the incidence and severity of graft-versus-host disease in patients with acute leukemia undergoing allogeneic transplantation
- (2008) M. Hamadani et al. BLOOD
- Regulation of different inflammatory diseases by impacting the mevalonate pathway
- (2008) Robert Zeiser et al. IMMUNOLOGY
- Graft-versus-host disease: suppression by statins
- (2008) Raewyn Broady et al. NATURE MEDICINE
- Oral High-Dose Atorvastatin Treatment in Relapsing-Remitting Multiple Sclerosis
- (2008) Friedemann Paul et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started